ReNeuron logo
ReNeuron logo

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’

Proactive Investors: ReNeuron gears up for Phase III stroke disability study

https://youtu.be/QJaKk3F-TQs

Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial

To view the full article click here…

CEO Presents at Cell & Gene Investor Day, April 2017, Boston

Section: News

  • News

© ReNeuron Group plc 2025 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer